<DOC>
	<DOCNO>NCT02936973</DOCNO>
	<brief_summary>The primary objective multicenter randomize control trial evaluate treatment effectiveness intervene simple obesity people catgut implantation preferred acupoints , excludes placebo effect ; secondary objective evaluate safety superiority treat simple obesity catgut implantation acupoints provide high-level evidence clinically .</brief_summary>
	<brief_title>Catgut Implantation Acupoints Treatment Simple Obesity</brief_title>
	<detailed_description>This randomize , double-blind sham-controlled clinical trial conduct Hubei Provincial Hospital TCM , Dongzhimen Hospital Beijing University Chinese Medicine First Hospital Hunan University Chinese Medicine . This study include following time point : treatment period 16 week screen follow-up period 24 week . The total study period 40 week . All patient randomize real catgut implantation acupoints group sham catgut implantation acupoints group.The primary outcome measurement study rate waistline reduction compare baseline . The secondary outcome measurement rate reduction weight , BMI , hipline , WHR PBF , change IWQOL-Lite compare baseline . These parameter evaluate week 0 , week 4 , week 8 , week 12 , week 16 , week 28 week 40 . Changes SF-36 , HAD SES compare baseline evaluate week 0 , week 16 week 40 . SF-36 IWQOL-Lite use evaluate obese patient quality life . HAD SES use evaluate psychological status . In addition , hepatorenal function , blood fat , liver bladder spleen colour ultrasound , FBG insulin concentration use evaluate whether catgut implantation acupoints improve physiological function obese patient .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<criteria>Inclusion criterion Patients recruit study meet follow inclusion criterion : 1. meeting diagnosis standard simple obesity Redefinition Processing Obesity Asia &amp; Pacific Area release WHO February 2000 ; 2. age : 1845 ; 3 . BMI : 25≤BMI &lt; 30 ; 4. waistline : male ≥95 cm ; female ≥85 cm ; 5. smoker change smoke habit least 2 month ; 6. willing accept abovedescribed intervention method . Exclusion criteria Patients follow criterion exclude study : 1. endocrine disease ( polycystic ovarian syndrome , Cushing 's Disease , hypothyroidism , among others ) ; 2. gestational diabetes uncontrolled hypertension ( SBP ≥160 mmHg ; DBP ≥100 mmHg ) [ 23 ] , lung , heart , liver kidney disease ; 3. nervous system disease mental disorder , history hospitalize depression , two instance paralepsy suicidal tendency ; 4. history clinical diagnosis eat disorder , bulimia cynorexia , anorexia ; weight change great 5 kg previous 3 month ; 5. history weight loss surgery history postoperative adhesion ; 6. take drug know influence weight appetite previous 3 month , diet pill , corticosteroid drug , antidepression drug , diazepam drug , nonselective body antihistamine , nicotine replacement , hypoglycaemic drug , plan give smoking drinking ; 7. pregnancy , lactation , plan become pregnant within 40 week ; 8. receive catgut implantation acupoints ; 9. participate clinical research obesity previous 3 month ; 10. protein allergy scar ; 11. skin disease eczema psoriasis ; 12. coagulation disorder , take warfarin , heparin anticoagulant drug ; 13. cooperative maintain treatment study period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>simple obesity</keyword>
	<keyword>catgut implantation</keyword>
</DOC>